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Abstract
Background: The first vaccine to prevent human papillomavirus (HPV) and cervical cancer has
been licensed, and in future, vaccination may be routinely offered to 10–14 year old girls. HPV
is a sexually transmitted virus and some parents may refuse consent for vaccination. Under-16s
in the UK have a right to confidential sexual health care without parental consent. We
investigated parents' views on making available HPV vaccination to adolescent minors at sexual
health clinics without parental consent.
Methods: This was a semi-qualitative analysis of views of parents of 11–12 year old school
children collected as part of a population-based survey of parental attitudes to HPV vaccination
in Manchester. Parents were firstly asked if they agreed that a well-informed child should be able
to request vaccination at a sexual health clinic without parental consent, and secondly, to provide
a reason for this answer. Ethical perspectives on adolescent autonomy provided the framework
for descriptive analysis.
Results: 307 parents answered the question, and of these, 244 (80%) explained their views.
Parents with views consistent with support for adolescent autonomy (n = 99) wanted to
encourage responsible behaviour, protect children from ill-informed or bigoted parents, and
respected confidentiality and individual rights. In contrast, 97 parents insisted on being involved
in decision-making. They emphasised adult responsibility for a child's health and guidance,
erosion of parental rights, and respect for cultural and moral values. Other parents (n = 48)
wanted clearer legal definitions governing parental rights and responsibilities or hoped for joint
decision-making. Parents resistant to adolescent autonomy would be less likely to consent to
future HPV vaccination, (67%) than parents supporting this principle (89%; p < 0.001).
Conclusion: In the UK, the principle of adolescent autonomy is recognised and logically should
include the right to HPV vaccination, but this may concern parents who would otherwise
approve vaccination.
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Background
The first vaccine to prevent cervical cancer was recently
approved for use in the European Union (Gardasil®,
Merck &Co, Inc.)[1]. This brings closer the possibility of
routine vaccination against human papillomavirus (HPV)
to prevent pre-cancerous cervical lesions and invasive dis-
ease [2]. This quadrivalent vaccine, which is highly effec-
tive against HPV types 6/11 (low risk) and HPV types 16/
18 (high risk), could have a significant public health
impact in reducing HPV prevalence, persistent HPV infec-
tion, cervical neoplasia and genital warts [3]. A bivalent
vaccine (Cervarix® GlaxoSmithKline) with similar levels of
protective efficacy against HPV types 16/18 is expected to
be licensed in 2007 [4]. The United States Centers for Dis-
eases Control has already recommended routine vaccina-
tion of Gardasil® for 11 and 12 year old girls, and 9–10
year olds at the discretion of their physician [5]. (Pre)-
adolescents are the main target group as the vaccine is pro-
phylactic and will be most effective if administered prior
to sexual initiation [6]. The public health impact will be
greatest if a high coverage of the target population is
achieved [7]. School vaccination programmes would be
feasible in the UK but acceptability by the public of rou-
tine vaccination against a sexually transmitted infection
(STI) is still uncertain and parental consent for vaccina-
tion would be necessary.
A number of studies of parental attitudes – mostly con-
ducted in the US – suggest a considerable interest in ado-
lescent HPV vaccination, with most parents in favour of
protecting their children [8]. We previously reported a
population-based survey in Manchester, UK, that assessed
the acceptability of HPV vaccines to parents of 11–12 year
old school children [9]. The study included parents from
a wide range of backgrounds, and 81% replied that they
would consent to HPV vaccination for their child,
although only 38% were definite in this view. Long-term
safety of the vaccine was an important issue, and a minor-
ity of parents would refuse on grounds that vaccination
could encourage early sexual debut or riskier sexual
behaviour. In view of the fact that, in the UK, at least 25%
of adolescents will have their first experience of sexual
intercourse before the age of 16 [10], and to ensure a high
population coverage, it may be necessary for HPV vaccines
to be available for under-16s without parental consent
[11]. In the UK, vaccines could be given in general prac-
tice, at sexual health clinics, or within targeted "catch-up"
programmes for women up to 26 years.
Consent for treatment is based on the ethical principle of
patient autonomy, a concept that has many definitions
[11,12] but is associated with the right to privacy and con-
fidentiality, acting according to one's own volition, self-
mastery, choosing one's own moral responsibility and
accepting responsibilities for one's choice. Consent is
valid if it is voluntary and the individual is both informed
and competent [13]. In the face of increased sexual and
reproductive health care needs of adolescents, many
countries have enacted "health services to minors" legal
Acts, lending support to a notion of "adolescent auton-
omy" [14]. In England the Law Lords ruled in 1985 that a
girl under 16 could consent for contraception if able to
understand the proposed treatment and it implications
[15]. Subsequently, the Fraser ruling provided guidance
for health workers on assessing the maturity and compe-
tency of a minor to comprehend the information given
[16]. As HPV is sexually transmitted, it would be logical to
make HPV vaccination routinely available to sexually
active minors whose parents had refused consent. This
could, however, stigmatise HPV vaccination and make it
more contentious, as some parents are opposed to confi-
dential sexual health services for minors [17]. To explore
this issue our survey included two items, the first asking if
parents would approve a well-informed child being
allowed to access the vaccine at a sexual health clinic with-
out parental consent, and the second to explain in their
own words the reason for their answer. In this paper we
report a semi-qualitative analysis of their responses, using
an ethical framework to explore parents' views on HPV
vaccination in the context of adolescent autonomy.
Methods
Study Procedures
The data described here are semi-qualitative, cross sec-
tional descriptive data. The methodology and results for
the main study, which was designed to sample randomly
parents of year 7 pupils (ages 11–12) in the city of Man-
chester, UK, have been reported in full elsewhere [9]. In
brief, all 26 inner-city community (state), voluntary-aided
(faith-based) and independent (private) secondary
schools were stratified into eight strata according to
school type and ethnicity, based on data supplied by the
Department for Education. Using a purpose-written com-
puter program, one school was randomly selected from
each stratum, with alternative second and third choice
schools available in the event of refusals This gave a
potential sample of about 1500 pupils and allowed sam-
pling across all school types. A questionnaire, eliciting
basic socio-economic data and parents' views on HPV,
was developed through group discussions and subsequent
piloting with parents, then mailed through the school
administration directly to parents. Parents were advised
that return of a completed questionnaire signified written
consent to the study. Ethnic response categories were
those defined in the 2001 census. Religion was catego-
rised as follows: None, Christian (Roman Catholic),
Christian (Protestant; state denomination), Muslim,
Hindu, Buddhist, Sikh, Jewish, Other. As knowledge
about HPV was low, key facts were given about HPV and
cervical cancer in the preamble to the questionnaire, andBMC Public Health 2007, 7:20 http://www.biomedcentral.com/1471-2458/7/20
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a separate information leaflet was provided. Despite a
response rate of 22% (n = 317), the major social and eth-
nic groups were well represented, as were religious views
– except for those of one non-participant school, which
was the only one of its type and could not be replaced.
HPV vaccine acceptance did not vary significantly across
socio-demographic groups.
The University of Manchester Committee on the Ethics of
Research on Human Beings approved the study.
Data analysis
Responses to the question of whether a well-informed
child should be able to request vaccination without
parental consent at a sexual health clinic were measured
using a five-point Likert scale (strongly agree, agree, disa-
gree, strongly disagree, don't know). For the detailed com-
ments, we followed a recommended method for analysis
of semi-qualitative survey data [18]. Comments were
entered verbatim on to computer and sub-categorised into
three groups representing parents giving positive, less pos-
itive or ambiguous responses. The numbers for each
group are discrete as viewpoints generally fell clearly into
one of the groups. Within each group, the responses were
classified into sub-themes related to ethical principles
(such as privacy and confidentiality, informed consent,
maleficence and beneficence) and comments illustrating
these were extracted for quotation. Parents received no
guidance on the definition of a "well-informed" child.
The categories were independently assigned by two
researchers and discrepancies were reviewed and jointly
agreed. To assess the background of parents with different
viewpoints, the child's ethnicity, religion, entitlement to
free school meals and parental age were cross-tabulated
against these categories and compared using Pearson's chi
square test.
Results
A total of 305 of 317 respondents (96.2%) answered the
closed question on provision of HPV vaccination at sexual
health clinics, and 13.8% (42) strongly agreed, 33.8%
(103) agreed, 26.6% (81) disagreed, 17.0% (52) strongly
disagreed, and 8.9% (27) could not decide. Of these, 80%
(244) of parents explained their viewpoint (open ques-
tion). Parents who had indicated that they could not
decide whether they agreed or disagreed with the concept
were less likely to offer any explanation. The responses to
the open and closed questions were cross-tabulated
(Table 1). More positive views largely accorded with the
agree/strongly disagree categories, as did the less positive
with the disagree/strongly disagree categories. "Other"
views were distributed across all categories.
Positive opinions (n = 99)
The largest group (n = 40) had a clear sense that children
who were well informed should be able to give autono-
mous consent to vaccination. As one parent said, "If my
child had read all about it and is willing to take the responsibil-
ity for his choice, then I would be proud of him" or, " Our chil-
dren are generally better informed and better able to make
decisions than we are, they deserve to have this respected". This
did not necessarily imply approval of early sexual activity,
but approval that the child was learning to make health
decisions. Some linked this to recognition of a child's
maturity. One said, "A child mature enough to request vacci-
nation does not need parental consent." Three other parents
made comments such as, "Any child who is attending sexual
health clinics would fall into a group who would benefit from
this vaccine. They should be able to request it – if they are hav-
ing sex and seem able to understand the issues". A somewhat
different perspective was presented by another group of
parents (n = 23), who considered it important to protect
children from parents who seemed not to act (in their
view) in the child's best interests (the principle of benefi-
cence). This was illustrated by the comment, "Parents are
not realistic about what their children do, and this may place
their children at risk", or, "Too many parents have their moral
views blinding them as to what their children actually get up to.
Children should be protected, regardless of this", or "It cannot
be bad for a child to seek protection from a disease." Another
group (n = 27) indicated that the main factor was respect
for a child's right to privacy. For example, "A child might be
in a sexual relationship and their parents don't know about it
and they want to keep it quiet without their parents finding
out." Nine other parents framed their response simply in
terms of children having a right to decide.




A well-informed child could request vaccination at sexual health clinics without parental consent 
(closed question)
Don't know Strongly disagree Disagree Agree Strongly agree Total (n)
Positive 3 0 0 68 28 99
Less Positive 4 41 46 6 0 97
O t h e r 9 61 7 1 244 8
T o t a l  ( n ) 1 64 76 38 63 2 2 4 4
n is the number in each groupBMC Public Health 2007, 7:20 http://www.biomedcentral.com/1471-2458/7/20
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Less positive opinions (n = 97)
Most of the opinions in this category reflected the view
that parents felt, for one reason or another, that they
should not be excluded from decision-making and that
parental rights took precedence over the child's rights.
Forty four made statements such as, "Parents should always
be informed" or, " My child doesn't request vaccination without
parental consent because we are Asian" or, "I have been
involved in decisions about all other vaccinations, so I should be
informed about this one." Some said that parents could not
take responsibility for children if they did not know what
the child was doing. A further group of 12 parents com-
plained that parents' rights to make decisions on behalf of
their children were being eroded as, "Far too much respon-
sibility for children's health and conduct is being taken out of
parent's hands, and, "It's bringing a barrier between child and
parents. Instead of parents discussing with their children, eth-
ics, morals and values, the government is allowing the by-pass
of parental authority and responsibility, while at other times,
eg. for truancy, forcing unreasonable parental authority."
Related to this was a set of viewpoints (n = 18) emphasis-
ing the importance of parental guidance (principle of
paternalism), "because, after all, a child is a child, so it is best
if he/she asks their parents for their permission as they have a
lot of knowledge."
One set of parents (n = 11) were explicit about parent's
involvement in medical consultations related to HPV vac-
cination, making comments such as "There could be a fam-
ily history which may make it (the vaccine) unsuitable," and
"In the event of side effects, how would parents know what to
monitor?" Three parents within this group added state-
ments to the effect that "parents should know about a child's
sexual activity." Another set of statements (n = 12) sug-
gested that sexual health clinics were unsuitable and did
harm (principle of maleficence) because moral issues
were neglected and children given selected information,
"Children... will be informed but often times children are not
the best judge to be able to weigh their decisions without parents
(adults who have values)" and "Who assesses, (and how)
whether the child is well informed ?" Nine of the 12 said that
attending sexual health clinics encouraged sexual promis-
cuity. In the words of one, "Unless parents and children are
taught together about the risks of a sexually promiscuous life, I
can see only a downward spiral of disease and social disintegra-
tion." Three of the twelve claimed that it would be unnec-
essary to provide a vaccine at sexual health clinics if it was
available in schools.
Other views (n = 48)
Age, rather than maturity, was the deciding factor for 22
parents, who wanted clearer legal guidelines. This was
indicated by comments such as, "Children are minors. An
age should be set for everything, drinking, sex etc and be the
same." This statement reflected a sense of confusion about
different legal ages of consent for these activities. Some
parents apparently disagreed with the current legal frame-
work that allows under-16s to be treated, for example,
"Children over the age of 16 – yes, but younger children should
not be taking medical advice without a parent." The remain-
der (n = 26) wanted children and parents to work things
out together, but their statements were normative rather
than a rejection of adolescent autonomy. For example,
one said, "A child should discuss such issues with a parent"
and another, "I wouldn't like my daughter to make a life-
changing decision without being able to talk to me."
Socio-demographic characteristics of the 244 parents were
compared (Table 2). Parental age, receipt of free school
meals and religion were not significantly associated with
views on consent, but there were significant differences
between ethnic groups, and White and Black Caribbean
parents were more supportive of adolescent autonomy.
Parents who had concerns about sexual health clinics
were less likely than those with favourable views to agree
to future HPV vaccination, even with parental consent
(67% versus 89%; chi square: p < 0.001).
Discussion
In the UK there is a high teenage pregnancy rate and an
epidemic of STIs [19]. The high and increasing prevalence
of HPV [20] among young women is probably due to
high-risk behaviour and biological immaturity of young
adolescents exposed to infection [21]. The government's
sexual health strategy promotes expansion of sexual
health services and a determined effort to make these
accessible to under-16s [22], often through avenues out-
side the clinical setting [23]. If projections about parental
acceptability of vaccination are correct, it can be antici-
pated that, if parental consent is mandatory, at least 20%
of under-16s will not be vaccinated against HPV. Strategic
decisions will be needed on whether to try and optimise
coverage by making the vaccine available without parental
consent, and whether this would provoke negative reac-
tions from parents.
In trying to answer these questions, it becomes obvious
how little research (as opposed to media coverage) has
been conducted, either in UK or elsewhere, on the accept-
ability to adults of policies allowing under-16s to be
treated without parental consent [24-26]. Our research
indicates strong, but divided, views on medical interven-
tion without parental consent as well as confusion about
the legal framework governing parental responsibility.
Parents with favourable views referred spontaneously to
children's ability to understand and process information,
although it remains unclear precisely how they inter-
preted "well-informed". They argued from an ethical per-
spective in support of adolescent autonomy as a
developmental, age-independent process of separationBMC Public Health 2007, 7:20 http://www.biomedcentral.com/1471-2458/7/20
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and detachment from the family [12] and this is consist-
ent with allowing a competent adolescent to access confi-
dential sexual health care. In reality, the right to treatment
is still mediated by an adult, but it is a health professional
instead of the parent. This role is approved by parents who
argue that this protects vulnerable adolescents, but is chal-
lenged by other parents who question whether health pro-
fessionals can judge what is in a child's best interests.
Their views corresponded to a more recent definition of
autonomy that emphasises maintaining "family connect-
edness" [12]. Largely based on US studies, family support
is considered to encourage healthy development and to
result in fewer risky behaviours [27-29] but is inconsistent
with the principles of confidential adolescent sexual
health provision. This is not to say that parents who want
to be involved in health decisions would stand in the way
of appropriate preventive or treatment strategies such as
HPV vaccination, but that they want to be involved in the
decision. We previously reported that 74% of parents
intended to make a joint decision about HPV vaccination
with their child and this was associated with support for
the vaccine [9]. In the current analysis, we further demon-
strate that some parents saw no need for the vaccine to be
available at sexual health clinics if it could be provided in
schools. For this reason, in the UK, a high HPV vaccine
coverage may be achievable through a school-based strat-
egy, as it was for adolescent hepatitis B vaccination [30],
because parental consent will be sought.
The ethical question remains, however, of the right of
adolescents to request the vaccine if, as minors, they sub-
sequently become sexually active without their parent's
knowledge and their parents earlier had declined consent.
As the principle of adolescent autonomy is legally recog-
nised in the UK, logically it should include the right to
HPV vaccination [31]. In the Gillick case, the Law Lords
focused on the issue of consent rather than a notion of
parental rights or powers. In fact the courts held the view
that parental rights did not exist, other than to safeguard
the best interests of the minor [32]. One scenario would
be to argue that HPV vaccination is different from other
sexual health interventions because effective cervical
screening programmes provide a safety net for adolescents
who subsequently develop cervical intraepithelial lesions.
This argument could not be applied with respect to genital
warts if a quadrivalent vaccine was in use. This is an
important consideration because in 2001 there were
32,185 diagnoses of genital warts in females, 29% of
which were in those under 20 years of age [33]. Another
approach would be to vaccinate under-16s without paren-
tal consent within a catch-up programme that was accessi-
ble to this age group. Catch-up programmes are expensive
and it is not clear whether vaccination will benefit women
already exposed to HPV [3] but they are quite likely to be
adopted as an interim measure. It would be important to
ensure that adolescents were aware of catch-up pro-
grammes as those who have not been vaccinated may feel
anxious if most of their peers received the vaccine.
There are a number of limitations to this study, notably
with the use of semi-qualitative data taken from surveys
[18], which is intended to provide insights not conveyed
Table 2: Socio-demographic profiles of parents holding different views on HPV vaccination without parental consent.
Vaccination without parental consent
Characteristic Positive % (No) Less Positive (%) No Other % (No) Total % (No)† p value*
Parental Age (years)
≤30 47.1 (8) 41.2 (7) 11.8 (2) 7.1 (17)
31 – 40 36.4 (40) 45.5 (50) 18.2 (20) 46.2 (110)
> 40 42.3 (47) 35.1 (39) 22.5 (25) 46.6 (111) 0.5
Child receives free school meals
No 45.5 (80) 36.9 (65) 17.6 (31) 73.6 (176)
Yes 30.2 (19) 46.0 (65) 23.8 (15) 26.4 (63) 0.1
Religion
None 46.3 (19) 36.6 (15) 17.1 (7) 17.1 (17)
Catholic 32.7 (16) 32.7 (16) 36.2 (17) 20.4 (49)
Protestant 44.2 (50) 41.6 (47) 14.2 (16) 47.1 (113)
Muslim 33.3 (6) 50.0 (9) 16.7 (3) 7.5 (18) 0.2
Ethnic Group
White 45.5 (75) 32.1 (53) 22.4 (37) 67.6 (165)
Black Caribbean 39.1 (9) 47.8 (11) 13.0 (3) 9.4 (23)
Black African 27.8 (5) 50.0 (9) 22.2 (4) 7.4 (18)
India Sub-continent 28.6 (8) 57.1 (16) 14.3 (4) 11.5 (28)
Others‡ 20.0 (2) 80.0 (8) 0.0 (0) 4.1 (10) 0.03
† Total varies due to occasional missing data * Pearson's chi square
‡ eg. Chinese, ArabBMC Public Health 2007, 7:20 http://www.biomedcentral.com/1471-2458/7/20
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by the quantitative data. Being partly quantitative, biases
in the survey could be reflected in the analysis, and with a
relatively low response rate, the results cannot be assumed
to represent all parents' views. A greater limitation is that
semi-qualitative data are not detailed and do not provide
the more informative type of data that can be gained from
in-depth qualitative approaches. Nevertheless, our study
provides some insights into the need for policy makers to
engage more effectively with parents on sexual health
matters. Parents rejecting the principle of adolescent
autonomy were more opposed to adolescent HPV vacci-
nation  per se. For adolescents, access to health care is
always mediated by gate keepers such as parents, health
providers and communities and it is vital not to under-
mine efforts to make it easier for them to obtain the health
care they require. A public debate is needed to allow all
perspectives to be considered and to help parents and pol-
icy makers to understand the ethical issues that underpin
adolescent autonomy, confidentiality and privacy [34], as
well as the skills required to talk to children and promote
adolescent self-regulation [35]. The doctor-patient rela-
tionship is the primary focus of ethics in medicine, and
clinicians must be prepared to discuss these issues with
adolescents and their parents [36].
Conclusion
Although recognising its benefits, some parents might dis-
approve of HPV vaccination without parental consent.
This could pose a dilemma in countries where adolescent
sexual autonomy is legally recognised and might contrib-
ute to the view that the vaccine encourages sexual promis-
cuity. Such concerns would need to be openly addressed
to avoid misunderstanding that the purpose of vaccina-
tion is prevention of cervical cancer.
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